Advanced search
Publication Cover
Expert Review of Vaccines Volume 12, 2013 - Issue 12
Submit an article Journal homepage
391
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Novel vaccine strategies against tuberculosis: a road less travelled

Supriya PokkaliJohns Hopkins University School of Medicine, Baltimore, MD 21231, USA
&
Sanjay JainJohns Hopkins University School of Medicine, Baltimore, MD 21231, USACorrespondence[email protected]
Pages 1373-1375 | Published online: 09 Jan 2014

References

  • WHO. Global tuberculosis control: WHO report. Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland (2012).
  • Horwitz MA, Harth G, Dillon BJ, Maslesa-Galic S. Enhancing the protective efficacy of Mycobacterium bovis BCG vaccination against tuberculosis by boosting with the Mycobacterium tuberculosis major secretory protein. Infect. Immun. 73(8), 4676–4683 (2005).
  • Baldwin Sl, D’souza C, Roberts AD et al. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect. Immun. 66(6), 2951–2959 (1998).
  • WHO. The immunological basis for immunization series: module 5: tuberculosis. The Immunological Basis for Immunization Series: Module 5: Tuberculosis (1993).
  • Rosenthal SR, Loewinsohne, Graham ML, Liveright D, Thorne G, Johnson V. BCG vaccination against tuberculosis in Chicago. A twenty-year study statistically analyzed. Pediatrics 28, 622–641 (1961).
  • Lalvani A, Sridhar S, Fordham Von Reyn C. Tuberculosis vaccines: time to reset the paradigm? Thorax doi:10.1136/thoraxjnl-2013-203456 (2013) ( Epub ahead of print).
  • Kaufmann SH. Fact and fiction in tuberculosis vaccine research: 10 years later. Lancet. Infect. Dis. 11(8), 633–640 (2011).
  • Achkar JM, Casadevall A. Antibody-mediated immunity against tuberculosis: implications for vaccine development. Cell Host Microbe. 13(3), 250–262 (2013).
  • Tameris MD, Hatherill M, Landry BS et al. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 381(9871), 1021–1028 (2013).
  • Be N, Kim K, Bishai W, Jain S. Pathogenesis of central nervous system tuberculosis. Curr. Mol. Med. 9(2), 94–99 (2009).
  • Rana FS, Hawken MP, Mwachari C et al. Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya. J. Acquir. Immune. Defic. Syndr. 24(1), 23–29 (2000).
  • Thwaites GE, Nguyen DB, Nguyen HD et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N. Engl. J. Med. 351(17), 1741–1751 (2004).
  • Brosch R, Gordon SV, Garnier T et al. Genome plasticity of BCG and impact on vaccine efficacy. Proc. Natl Acad. Sci. USA 104(13), 5596–5601 (2007).
  • Romanus V. Tuberculosis in Bacillus Calmette-Guerin-immunized and unimmunized children in Sweden: a ten-year evaluation following the cessation of general Bacillus Calmette-Guerin immunization of the newborn in 1975. Pediatr. Infect. Dis. J. 6(3), 272–280 (1987).
  • Padungchan S, Konjanart S, Kasiratta S, Daramas S, Ten Dam HG. The effectiveness of BCG vaccination of the newborn against childhood tuberculosis in Bangkok. Bull. World Health Organ. 64(2), 247–258 (1986).
  • Ottenhoff TH, Kaufmann SH. Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog. 8(5), e1002607 (2012).
  • Rich AR, Mccordock HA. The pathogenesis of tuberculous meningitis. Bull. Johns. Hopkins Hosp. 52, 5–37 (1933).
  • Kim KS. Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat. Rev. Neurosci. 4(5), 376–385 (2003).
  • Be N, Bishai W, Jain S. Role of Mycobacterium tuberculosis pknD in the Pathogenesis of central nervous system tuberculosis. BMC Microbiol. 12(1), 7 (2012).
  • Skerry C, Pokkali S, Pinn M et al. Vaccination with Recombinant mycobacterium tuberculosis PknD attenuates bacterial dissemination to the brain in guinea pigs. PLoS ONE 8(6), e66310 (2013).
  • Peirs P, Parmentier B, De Wit L, Content J. The Mycobacterium bovis homologous protein of the Mycobacterium tuberculosis serine/threonine protein kinase Mbk (PknD) is truncated. FEMS Microbiol. Lett. 188(2), 135–139 (2000).
  • Zucchi FC, Tsanaclis AM, Moura-Dias Q, JR. et al. Modulation of angiogenic factor VEGF by DNA-hsp65 vaccination in a murine CNS tuberculosis model. Tuberculosis (Edinb.) 93(3), 373–380 (2013).
  • Tsenova L, Harbacheuski R, Moreira AL et al. Evaluation of the Mtb72F polyprotein vaccine in a rabbit model of tuberculous meningitis. Infect. Immun 74(4), 2392–2401 (2006).
  • Principi N, Esposito S. Diagnosis and therapy of tuberculous meningitis in children. Tuberculosis (Edinb.) 92(5), 377–383 (2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.